These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33595258)

  • 21. Use of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation after intestinal perforation.
    Tagami T; Matsui H; Fushimi K; Yasunaga H
    Front Med (Lausanne); 2015; 2():7. PubMed ID: 25767801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant human soluble thrombomodulin in severe sepsis: a systematic review and meta-analysis.
    Yamakawa K; Aihara M; Ogura H; Yuhara H; Hamasaki T; Shimazu T
    J Thromb Haemost; 2015 Apr; 13(4):508-19. PubMed ID: 25581687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant Human-Soluble Thrombomodulin Contributes to Reduced Mortality in Sepsis Patients With Severe Respiratory Failure: A Retrospective Observational Study Using a Multicenter Dataset.
    Yoshihiro S; Sakuraya M; Hayakawa M; Ono K; Hirata A; Takaba A; Kawamura N; Tsutsui T; Yoshida K; Hashimoto Y
    Shock; 2019 Feb; 51(2):174-179. PubMed ID: 29596106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant human soluble thrombomodulin administration improves sepsis-induced disseminated intravascular coagulation and mortality: a retrospective cohort study.
    Kato T; Sakai T; Kato M; Hagihara M; Hasegawa T; Matsuura K; Nakagawa T
    Thromb J; 2013 Feb; 11(1):3. PubMed ID: 23414216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant human soluble thrombomodulin improves mortality in patients with sepsis especially for severe coagulopathy: a retrospective study.
    Kato T; Matsuura K
    Thromb J; 2018; 16():19. PubMed ID: 30158838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Web-based application for predicting the potential target phenotype for recombinant human thrombomodulin therapy in patients with sepsis: analysis of three multicentre registries.
    Goto T; Kudo D; Uchimido R; Hayakawa M; Yamakawa K; Abe T; Shiraishi A; Kushimoto S
    Crit Care; 2022 May; 26(1):145. PubMed ID: 35590381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A systematic review and meta-analysis of recombinant human soluble thrombomodulin for the treatment of DIC associated with hematological malignancies.
    Kawano N; Fukatsu M; Yamakawa K; Seki Y; Wada H; Okamoto K; Ikezoe T
    Int J Hematol; 2024 Apr; 119(4):416-425. PubMed ID: 38270783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of recombinant human thrombomodulin and gabexate mesylate for treatment of disseminated intravascular coagulation (DIC) with sepsis following emergent gastrointestinal surgery: a retrospective study.
    Akahoshi T; Sugimori H; Kaku N; Tokuda K; Nagata T; Noda E; Morita M; Hashizume M; Maehara Y
    Eur J Trauma Emerg Surg; 2015 Oct; 41(5):531-8. PubMed ID: 26038004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant Human Soluble Thrombomodulin in Sepsis-Induced Coagulopathy: An Updated Systematic Review and Meta-Analysis.
    Yamakawa K; Murao S; Aihara M
    Thromb Haemost; 2019 Jan; 119(1):56-65. PubMed ID: 30597500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment of disseminated intravascular coagulation (DIC) model by a single iv administration of Escherichia coli-derived lipopolysaccharide (LPS) to cynomolgus monkeys and evaluation of its pathophysiological status.
    Minomo H; Inoue K; Sakaki S; Okazaki T; Kobayashi K; Inoue K; Miyata A
    J Pharmacol Sci; 2017 Feb; 133(2):88-95. PubMed ID: 28215474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.
    Abe M; Tsushima K; Matsumura T; Ishiwata T; Ichimura Y; Ikari J; Terada J; Tada Y; Sakao S; Tanabe N; Tatsumi K
    Drug Des Devel Ther; 2015; 9():5755-62. PubMed ID: 26566367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of Recombinant Human Soluble Thrombomodulin in Treating Disseminated Intravascular Coagulation Complicating Allogeneic Hematopoietic Stem Cell Transplantation.
    Inoue Y; Matsunawa M; Sano F; Miura I
    Acta Haematol; 2018; 140(2):121-127. PubMed ID: 30227394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of recombinant thrombomodulin for poor prognostic cases of acute exacerbation in idiopathic interstitial pneumonia: secondary analysis of the SETUP trial.
    Arai T; Kida H; Ogata Y; Marumo S; Matsuoka H; Gohma I; Yamamoto S; Mori M; Sugimoto C; Tachibana K; Akira M; Inoue Y
    BMJ Open Respir Res; 2020 May; 7(1):. PubMed ID: 32423894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis: A historically controlled study.
    Sakamoto S; Shimizu H; Isshiki T; Sugino K; Kurosaki A; Homma S
    Respir Investig; 2018 Mar; 56(2):136-143. PubMed ID: 29548651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant Thrombomodulin Modulates Murine Colitis Possibly via High-Mobility Group Box 1 Protein Inhibition.
    Ueda T; Higashiyama M; Narimatsu K; Yasutake Y; Kurihara C; Okada Y; Watanabe C; Yoshikawa K; Maruta K; Komoto S; Tomita K; Nagao S; Hokari R; Miura S
    Digestion; 2015; 92(2):108-19. PubMed ID: 26302768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognosis of disseminated intravascular coagulation associated with hematologic malignancy and its response to recombinant human thrombomodulin.
    Kurita N; Sakamoto T; Kato T; Kusakabe M; Yokoyama Y; Nishikii H; Sakata-Yanagimoto M; Obara N; Hasegawa Y; Chiba S
    Thromb Res; 2019 Jan; 173():57-64. PubMed ID: 30472436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of efficacy between continuous hemodiafiltration with a PMMA membrane hemofilter and a PAN membrane hemofilter in the treatment of a patient with septic acute renal failure.
    Matsuda K; Moriguchi T; Harii N; Goto J
    Transfus Apher Sci; 2009 Feb; 40(1):49-53. PubMed ID: 19103511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant Human Thrombomodulin in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
    Kataoka K; Taniguchi H; Kondoh Y; Nishiyama O; Kimura T; Matsuda T; Yokoyama T; Sakamoto K; Ando M
    Chest; 2015 Aug; 148(2):436-443. PubMed ID: 25811735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic Potential of Thrombomodulin in Renal Fibrosis of Nephrotoxic Serum Nephritis in Wistar-Kyoto Rats.
    Kanazawa N; Iyoda M; Tachibana S; Matsumoto K; Wada Y; Suzuki T; Iseri K; Shibata T
    Kidney Blood Press Res; 2020; 45(3):391-406. PubMed ID: 32146474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of disseminated intravascular coagulation: current insights on antithrombin and thrombomodulin treatments.
    Hayakawa M
    Open Access Emerg Med; 2018; 10():25-29. PubMed ID: 29343993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.